SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear Tire & Rubber is drawing significant community interest as investors weigh its potential as an undervalued turnaround play, supported by ongoing balance sheet deleveraging, cost-saving initiatives, and recent asset sales. While some traders are monitoring technical recovery patterns and bullish institutional activity, others remain cautious, debating the long-term impact of macroeconomic headwinds on the tire sector.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to new executive orders prioritizing the development of fault-tolerant quantum computing and post-quantum cryptography, fueling active community debate regarding long-term potential versus short-term volatility. While some participants view recent government policy support as a massive tailwind for future growth, others are actively trading the name through aggressive shorting and option hedging as they question the company's high valuation and historical price fluctuations.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is facing extreme selling pressure and declining share price, driven by deep-seated investor frustration over persistent dilution fears and management's perceived lack of strategic execution. Despite promising scientific progress and FDA fast-track designations for its oncology pipeline, the community remains heavily divided between long-term believers in the potential of VS-7375 and disillusioned investors who see the current valuation as a failure of leadership.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate its pivot toward agentic AI orchestration, with the community sharply divided over whether high short interest and institutional accumulation will trigger a squeeze or if the stock's price stagnation reflects ongoing concerns about growth. Investors are actively balancing the company's newfound GAAP profitability and strong balance sheet against skepticism regarding its ability to compete with larger software giants in the evolving AI space.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is trending as traders debate the company's defensive strength amid volatile energy markets, with significant community interest in how its stock performance correlates with geopolitical tensions, crude oil fluctuations, and ongoing share buyback programs.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently experiencing heightened volatility and trading activity as investors speculate on potential M&A prospects, following the company's decision to close its internal research facilities and prioritize external innovation. While the community remains divided between long-term holders frustrated by past performance and traders reacting to the recent technical breakout and high short interest, the discourse is heavily focused on whether these operational shifts signal an impending buyout or a strategic pivot toward sustainable profitability.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is seeing heightened activity as the community closely watches the ongoing proxy battle between management and its former CEO, while simultaneously tracking for a long-awaited anchor tenant announcement to validate its massive AI power infrastructure potential. Investors are actively debating the impact of the company's recent financing moves and internal governance shifts on the stock's ability to maintain momentum in the data center sector.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending following the disclosure of a significant new long position by high-profile investor Michael Burry, who cited the company's inflection point and growth potential in regulated sports betting and prediction markets. The community remains divided, with some investors focusing on these growth catalysts while skeptics continue to voice concerns regarding long-term price stagnation, management's performance, and intense competitive pressures within the sector.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened community engagement driven by the recent passage of a governance vote and optimism surrounding upcoming infrastructure updates and potential exchange developments. Investors are actively discussing the token's deflationary mechanics and long-term comeback potential, with the community closely tracking the network's stability and historical support levels.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum is generating significant buzz following its recent IPO as investors weigh its high valuation against the massive growth expectations of the quantum computing sector. While the community is actively debating the company's long-term commercial scalability and Honeywell's majority stake, traders are closely monitoring how the stock performs in relation to other quantum players and recent government initiatives in the space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VSTM  
$ANL  $ERAS $IMRX  $RVMD   
August 28, 2023 
Verastem Oncology Enters Discovery and Development Collaboration  
with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers 
https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-enters-discovery-and-development-collaboration

Synergistic Collaboration Based on Strengths of Verastem Oncology's Pipeline and Development Expertise and GenFleet Therapeutics' Discovery Capabilities Exclusive Option for Verastem Oncology to License Up to Three Programs with Development and Commercialization Rights Outside China BOSTON

Verastem, Inc.

Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers | Verastem, Inc.

StockTwits Web

Adlai Nortye Ltd. American

Erasca Inc

Immuneering Corp

Revolution Medicines Inc

   
August 28, 2023 
Verastem Oncology Enters Discovery and Development Collaboration  
with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers 
